Heartflow (HTFL) Asset Writedowns and Impairment (2024 - 2025)

Heartflow's (HTFL) quarterly Asset Writedowns and Impairment came in at $359000.0 in Q4 2025, up 247.13% year-on-year from $103419.1 in Q4 2024, and up 247.13% quarter-over-quarter from -$244000.0 in Q4 2024.

Heartflow (HTFL) Asset Writedowns and Impairment (2024 - 2025) Analysis & Trends

Heartflow's Asset Writedowns and Impairment history runs 2 years deep, the most recent figure standing at $359000.0 for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 247.13% year-over-year to $359000.0 in Q4 2025; TTM through Dec 2025 was $116000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $188000.0, up 177.05% from the prior year.
  • Asset Writedowns and Impairment advanced to $359000.0 in Q4 2025 per HTFL's latest filing, from -$244000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $359000.0 in Q4 2025 and bottomed at -$244000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 31.83 Bn 24.52 Bn 662.02 Mn
2 BrightSpring Health Services 14.58 Bn 13.68 Bn 482.22 Mn
3 Healthequity 8.29 Bn 8.02 Bn 256.31 Mn
4 Hinge Health 5.96 Bn 5.65 Bn 154.23 Mn
5 10x Genomics 5.79 Bn 5.26 Bn 106.18 Mn
6 MiniMed 4.49 Bn 4.19 Bn 480.00 Mn
7 Waystar Holding 4.49 Bn 4.42 Bn 216.84 Mn
8 Doximity 3.98 Bn 3.23 Bn 125.97 Mn
9 Privia Health 3.18 Bn 2.76 Bn -
10 Heartflow 916.56 Mn 739.77 Mn 39.06 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 359,000.00
Dec 31, 2025 359,000.00
Dec 31, 2024 -244,000.00
Dec 31, 2024 -244,000.00
Sep 30, 2024 1,000.00
Sep 30, 2024 1,000.00